Patricia Townsend Cohen

Title: Patricia Townsend Cohen: Innovator in Protein Phosphatase Research

Introduction

Patricia Townsend Cohen is a distinguished inventor based in Dundee, GB. She has made significant contributions to the field of biochemistry, particularly in the area of protein phosphatases. With a total of 2 patents, her work has implications for understanding insulin resistance and related diseases.

Latest Patents

Cohen's latest patents include groundbreaking research on protein phosphatase 1 binding protein, specifically the R5 - Human PPP1R5 polypeptides and the DNA (RNA) encoding such PPP1R5. This invention discloses a procedure for producing these polypeptides using recombinant techniques. Additionally, her patents outline methods for utilizing PPP1R5, as well as compounds that inhibit or stimulate its activity for treating dysfunctions or diseases associated with insulin resistance in glycogen synthesis. Furthermore, her work includes diagnostic assays for detecting diseases related to mutations in nucleic acid sequences and altered concentrations of the polypeptides.

Career Highlights

Throughout her career, Patricia has worked with notable companies such as SmithKline Beecham Corporation and Novo Nordisk A/S. Her experience in these organizations has allowed her to advance her research and contribute to significant scientific advancements.

Collaborations

Cohen has collaborated with esteemed colleagues, including Phillip Cohen and Peter R Young. These partnerships have enriched her research and expanded the impact of her inventions.

Conclusion

Patricia Townsend Cohen's innovative work in the field of protein phosphatases has led to important advancements in understanding insulin resistance and related diseases. Her contributions continue to influence the scientific community and pave the way for future research.